Jingpo Li

Hebei General Hospital

Papers

1

Total Citations

1

H-Index

1

About

Dr. Jingpo Li is a clinical researcher whose work focuses on perioperative nephrology and urological oncology. In a landmark 2025 systematic review and meta-analysis, Li identified and quantified the key risk factors for acute kidney injury (AKI) following radical cystectomy—a major procedure for bladder cancer. By synthesizing data from multiple English-language databases, this work provides clinicians with evidence-based criteria to stratify high-risk patients and implement targeted preventive interventions. Although the study is recent, its methodological rigor and clinical relevance have already secured its place as a foundational reference in the field, earning its first citation. Li’s contribution addresses a critical gap in postoperative care, where AKI significantly impacts patient morbidity and mortality. This research not only advances understanding of renal complications in urological surgery but also offers a practical framework for improving outcomes. As the meta-analysis gains traction, Dr. Li is positioned to become a leading voice in perioperative risk assessment and nephroprotective strategies in urology.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Risk factors for acute kidney injury following radical cystectomy: a systematic review and meta-analysis
1 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Hebei General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago